Jieying Zhou

LZ-106, a novel analog of enoxacin, inducing apoptosis via activation of ROS-dependent DNA damage response in NSCLCs

Lin Yang, Yinan Yuan, Chengyu Fu et al. · Free Radical Biology and Medicine · 2016 · 34 citations

Novel Analog, Oncogenic Agent, Medicine +7

AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma

Di Pan, Wanwan Yang, Yao Zeng et al. · Oncogene · 2022 · 31 citations

Cancer Research, Medicine, Tumor Suppressor +6

Hepatic Stellate Cell‐Targeting Micelle Nanomedicine for Early Diagnosis and Treatment of Liver Fibrosis

Lei Wang, Jieying Zhou, Jian Wang et al. · Advanced Healthcare Materials · 2024 · 22 citations · Full text

DNA and RNA editing without sequence limitation using the flap endonuclease 1 guided by hairpin DNA probes

Kun Tian, Yongjian Guo, Bingjie Zou et al. · Nucleic Acids Research · 2020 · 21 citations · Full text

Flap Endonuclease 1, Hairpin Dna Probe, In Vivo Gene Therapy +22

G1 phase cell cycle arrest in NSCLC in response to LZ-106, an analog of enoxacin, is orchestrated through ROS overproduction in a P53-dependent manner

Lin Yang, Jieying Zhou, Fei Meng et al. · Carcinogenesis · 2018 · 13 citations

Ros Overproduction, Cell Cycle Analysis, Cell Death +19